PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Alimemazine tartrate
Presentation Product Chemical substance Chapter Items dispensed
Alimemazine 10mg tablets
0304010Y0AAADAD
Alimemazine tartrate Alimemazine tartrate Respiratory System 3,494
Alimemazine 7.5mg/5ml oral solution
0304010Y0AAABAB
Alimemazine tartrate Alimemazine tartrate Respiratory System 2,132
Alimemazine 30mg/5ml oral solution
0304010Y0AAACAC
Alimemazine tartrate Alimemazine tartrate Respiratory System 1,204
Alimemazine 7.5mg/5ml oral solution sugar free
0304010Y0AABCBC
Alimemazine tartrate Alimemazine tartrate Respiratory System 455
Alimemazine 10mg/5ml oral solution sugar free
0304010Y0AABDBD
Alimemazine tartrate Alimemazine tartrate Respiratory System 251
Alimemazine 30mg/5ml oral solution sugar free
0304010Y0AABBBB
Alimemazine tartrate Alimemazine tartrate Respiratory System 224
Alimemazine 1.5mg/5ml oral solution
0304010Y0AABABA
Alimemazine tartrate Alimemazine tartrate Respiratory System No data available
Alimemazine 10mg/5ml oral solution
0304010Y0AAAYAY
Alimemazine tartrate Alimemazine tartrate Respiratory System No data available
Alimemazine 15mg/5ml oral solution
0304010Y0AAAUAU
Alimemazine tartrate Alimemazine tartrate Respiratory System No data available
Alimemazine 5mg/5ml oral solution
0304010Y0AAAVAV
Alimemazine tartrate Alimemazine tartrate Respiratory System No data available
Alimemazine 5mg/5ml oral suspension
0304010Y0AAAZAZ
Alimemazine tartrate Alimemazine tartrate Respiratory System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.